Tag Archives: FBR Capital

Agora (API) was Upgraded to a Buy Rating at B.Riley FBR

Agora (API – Research Report) received a Buy rating from B.Riley FBR analyst FBR Capital on June 12. The company’s shares closed last Tuesday at $47.74. Currently, the analyst consensus on Agora is a Moderate Buy with an average price

B.Riley FBR Upgrades Agora (API) to Buy

Agora (API – Research Report) received a Buy rating from B.Riley FBR analyst FBR Capital on August 13. The company’s shares closed last Tuesday at $47.74. Agora has an analyst consensus of Moderate Buy, with a price target consensus of

Post Earnings Beat, Galena Biopharma (GALE) on The Radar Due to Some Positive Drivers

Shares of biopharmaceutical company Galena Biopharma Inc. (NASDAQ: GALE) have been on a steady decline, falling by more than 90% during the past six months. On Friday, the stock closed at $2.83 after hitting its 52-week low of $2.61 during

FBR & Co Are Cautious on Financial Stocks, SunTrust Banks (STI) Among Top Rated Banks

SunTrust logo

The year 2016 did not exactly go along the expectations for the banking stocks, in lieu of the predicted four rounds of interest rate hikes, banks were hit with falling oil prices, delayed interest rate hike, and Brexit. According to the

Gap Receives a Hold from FBR Capital

FBR Capital analyst Susan Anderson reiterated a Hold rating on Gap (NYSE: GPS) today and set a price target of $22. The company’s shares opened today at $24.26. Anderson observed, “GPS reported September SSS of –3% (versus FBR/consensus of –2.1%/–3.6%

FBR Capital Thinks Alnylam Pharma’s Stock is Going to Recover

FBR Capital analyst Christopher James reiterated a Buy rating on Alnylam Pharma (NASDAQ: ALNY) yesterday and set a price target of $100. The company’s shares opened today at $36.10, close to its 52-week low of $33.17. James noted, “After the